CRINO', Lucio
CRINO', Lucio
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
2014 Vansteenkiste, J; Crino', Lucio; Dooms, C; Douillard, J. Y.; Faivre Finn, C; Lim, E; Rocco, G; Senan, S; Schil, P. V.; Veronesi, G; Stahel, R; Peters, S; Felip, E.
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
2014 Besse, B; Adjei, A; Baas, P; Meldgaard, P; Nicolson, M; Paz, Aresl; Reck, M; Smit, E. F.; Syrigos, K; Stahelr, ; Felip, E; Peters, S; Crino', Lucio; Panel, Members
A Hybrid Model of Nucleotide Excision Repair in Neoplastic diseases and in vitro Experiments
2006 Bianconi, Fortunato; Valigi, Paolo; Crino', Lucio; V., Ludovini; S., Piattoni; A., Orleth; M., Tonato
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung
2015 Bianconi, Fortunato; Baldelli, Elisa; Patiti, Federico; Valigi, Paolo; Haura, Eric B.; Crinò, Lucio; Ludovini, Vienna; Petricoin, Emanuel; Pierobon, Mariaelena
A prospective study on survival in cancer patients with and without venous thromboembolism.
2014 Agnelli, Giancarlo; Verso, Melina; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino', Lucio; Labianca, R.
A randomized discontinuation phase II trial of ridaforolimus in non-small cell lung cancer (NSCLC) patients with KRAS mutations.
2012 Riely, Gj; Brahmer, Jr; Planchard, D; Crino', Lucio; Doebele, Rc; Lopez, Lam; Gettinger, Sn; Schumann, C; Li, Xy; Atkins, Bm; Ebbinghaus, S; Rosell, R.
Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors
2014 Landi, L; Tiseo, M; Chiari, R; Ricciardi, S; Rossi, E; Galetta, D; Novello, S; Milella, M; D'Incecco, A; Minuti, G; Tibaldi, C; Salvini, J; Facchinetti, F; Haspinger, E. R.; Cortinovis, D; Santo, A; Banna, G; Catino, A; Giajlevra, M; Crino', Lucio; De Marinis, F; Cappuzzo, F.
Acute myeloblastic leukemia after adjuvant chemo¬therapy with melphalan in breast cancer. Case report with cytogenetic analysis.
1983 Gori, S; Donti, Emilio; Venti, G; Mecucci, Cristina; Crino', Lucio; Tonato, M.
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
2015 Kelly, Karen; Altorki, Nasser K.; Eberhardt, Wilfried E. E.; Obrien, Mary E. R.; Spigel, David R.; Crino', Lucio; Tsai, Chun Ming; Kim, Joo Hang; Cho, Eun Kyung; Hoffman, Philip C.; Orlov, Sergey V.; Serwatowski, Piotr; Wang, Jiuzhou; Foley, Margaret A.; Horan, Julie D.; Shepherd, Frances A.
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study
2014 Gridelli, C; De Marinis, F; Ardizzoni, A; Novello, S; Fontanini, G; Cappuzzo, F; Grossi, F; Santo, A; Cortinovis, D; Favaretto, A; Lorusso, V; Galetta, D; Siena, S; Bettini, A; Iurlaro, M; Caprioli, A; Crino', Lucio; LIFE Study, Team
Afatinib In Egfr Mutant Non-small-cell Lung Cancer Patients With Acquired Resistance To Reversible Egfr-tkis
2013 Cappuzzo, F; Tiseo, M; Chiari, R; Landi, L; Ricciardi, S; Rossi, E; Galetta, D; Novello, S; Milella, M; D'Incecco, A; Haspinger, Er; Cortinovis, D; Santo, A; Banna, G; Facchi Netti, F; Levra, Mg; Vari, S; Crino', Lucio; Marinis, Fd
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
2012 Miller, Va; Hirsh, V; Cadranel, J; Chen, Ym; Park, K; Kim, Sw; Zhou, Cc; Su, Wc; Wang, Mz; Sun, Y; Heo, Ds; Crino', Lucio; Tan, Eh; Chao, Ty; Shahidi, M; Cong, Xj; Lorence, Rm; Yang, Hjc
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
2004 Cappuzzo, F.; Magrini, E.; Ceresoli, G.; Bartolini, S.; Rossi, E.; Ludovini, V.; Gregorc, V.; Ligorio, C.; Cancellieri, A.; Damiani, S.; Spreafico, A.; Paties, C.; Lombardo, L.; Calandri, C.; Bellezza, Guido; Tonato, M.; Crino', Lucio
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series
2016 Metro, Giulio; Lunardi, Gianluigi; Bennati, Chiara; Chiarini, Pietro; Sperduti, Isabella; Ricciuti, Biagio; Marcomigni, Luca; Costa, Cinzia; Crino', Lucio; Floridi, Piero; Gori, Stefania; Chiari, Rita
ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients Results of the First Italian External Quality Assurance Scheme
2014 Marchetti, A; Barberis, M; Papotti, M; Rossi, G; Franco, R; Malatesta, S; Buttitta, F; Ardizzoni, A; Crino', Lucio; Gridelli, C; Taddei, G. L.; Clemente, C; Scagliotti, G; Normanno, N; Pinto, C.
An approach for optimally extending mathematical models of signaling networks using omics data
2015 Bianconi, Fortunato; Patiti, Federico; Baldelli, Elisa; Crino', Lucio; Valigi, Paolo
An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
2012 Grunwald, V; Karakiewicz, Pi; Bavbek, Se; Miller, K; Machiels, Jp; Lee, Sh; Larkin, J; Bono, P; Rha, Sy; Castellano, D; Blank, Cu; Knox, Jj; Hawkins, R; Anak, O; Rosamilia, M; Booth, J; Pirotta, N; Bodrogi, I; Crino', Lucio; REACT Study, Group
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer
2019 Baldelli, Elisa; Hodge, K. Alex; Campbell, Michael J.; Bellezza, Guido; Demsko, Perry; Ludovini, Vienna; Sidoni, Angelo; Vandenberg, Scott; Bolen, Jennifer; Mandarano, Martina; Shah, Neil; Blackburn, Mattew; Liotta, Lance; Crino', Lucio; Giaccone, Giuseppe; Petricoin III, Emanuel F.; Pierobon, Mariaelena
Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
2014 Marchetti, A; Grammastro, M. D.; Felicioni, L; Malatesta, S; Filice, G; Centi, I; Pas, T. D.; Santoro, A; Chella, A; Brandes, A. A.; Venturino, P; Cuccurullo, F; Crino', Lucio; Buttitta, F.
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
2008 Ludovini, V.; Pistola, L.; Gregorc, V.; Rulli, E.; Floriani, I.; Di Carlo, L.; Ragusa, Mark; Daddi, Giuliano; Betti, M.; Tofanetti, F.; Bellezza, Guido; Sidoni, Angelo; Tognellini, R.; Crino', Lucio; Tonato, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up | 2014 | Vansteenkiste, J; Crino', Lucio; Dooms, C; Douillard, J. Y.; Faivre Finn, C; Lim, E; Rocco, G; Senan, S; Schil, P. V.; Veronesi, G; Stahel, R; Peters, S; Felip, E. | |
| 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease | 2014 | Besse, B; Adjei, A; Baas, P; Meldgaard, P; Nicolson, M; Paz, Aresl; Reck, M; Smit, E. F.; Syrigos, K; Stahelr, ; Felip, E; Peters, S; Crino', Lucio; Panel, Members | |
| A Hybrid Model of Nucleotide Excision Repair in Neoplastic diseases and in vitro Experiments | 2006 | Bianconi, Fortunato; Valigi, Paolo; Crino', Lucio; V., Ludovini; S., Piattoni; A., Orleth; M., Tonato | |
| A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung | 2015 | Bianconi, Fortunato; Baldelli, Elisa; Patiti, Federico; Valigi, Paolo; Haura, Eric B.; Crinò, Lucio; Ludovini, Vienna; Petricoin, Emanuel; Pierobon, Mariaelena | |
| A prospective study on survival in cancer patients with and without venous thromboembolism. | 2014 | Agnelli, Giancarlo; Verso, Melina; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino', Lucio; Labianca, R. | |
| A randomized discontinuation phase II trial of ridaforolimus in non-small cell lung cancer (NSCLC) patients with KRAS mutations. | 2012 | Riely, Gj; Brahmer, Jr; Planchard, D; Crino', Lucio; Doebele, Rc; Lopez, Lam; Gettinger, Sn; Schumann, C; Li, Xy; Atkins, Bm; Ebbinghaus, S; Rosell, R. | |
| Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors | 2014 | Landi, L; Tiseo, M; Chiari, R; Ricciardi, S; Rossi, E; Galetta, D; Novello, S; Milella, M; D'Incecco, A; Minuti, G; Tibaldi, C; Salvini, J; Facchinetti, F; Haspinger, E. R.; Cortinovis, D; Santo, A; Banna, G; Catino, A; Giajlevra, M; Crino', Lucio; De Marinis, F; Cappuzzo, F. | |
| Acute myeloblastic leukemia after adjuvant chemo¬therapy with melphalan in breast cancer. Case report with cytogenetic analysis. | 1983 | Gori, S; Donti, Emilio; Venti, G; Mecucci, Cristina; Crino', Lucio; Tonato, M. | |
| Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial | 2015 | Kelly, Karen; Altorki, Nasser K.; Eberhardt, Wilfried E. E.; Obrien, Mary E. R.; Spigel, David R.; Crino', Lucio; Tsai, Chun Ming; Kim, Joo Hang; Cho, Eun Kyung; Hoffman, Philip C.; Orlov, Sergey V.; Serwatowski, Piotr; Wang, Jiuzhou; Foley, Margaret A.; Horan, Julie D.; Shepherd, Frances A. | |
| Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study | 2014 | Gridelli, C; De Marinis, F; Ardizzoni, A; Novello, S; Fontanini, G; Cappuzzo, F; Grossi, F; Santo, A; Cortinovis, D; Favaretto, A; Lorusso, V; Galetta, D; Siena, S; Bettini, A; Iurlaro, M; Caprioli, A; Crino', Lucio; LIFE Study, Team | |
| Afatinib In Egfr Mutant Non-small-cell Lung Cancer Patients With Acquired Resistance To Reversible Egfr-tkis | 2013 | Cappuzzo, F; Tiseo, M; Chiari, R; Landi, L; Ricciardi, S; Rossi, E; Galetta, D; Novello, S; Milella, M; D'Incecco, A; Haspinger, Er; Cortinovis, D; Santo, A; Banna, G; Facchi Netti, F; Levra, Mg; Vari, S; Crino', Lucio; Marinis, Fd | |
| Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial | 2012 | Miller, Va; Hirsh, V; Cadranel, J; Chen, Ym; Park, K; Kim, Sw; Zhou, Cc; Su, Wc; Wang, Mz; Sun, Y; Heo, Ds; Crino', Lucio; Tan, Eh; Chao, Ty; Shahidi, M; Cong, Xj; Lorence, Rm; Yang, Hjc | |
| Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer | 2004 | Cappuzzo, F.; Magrini, E.; Ceresoli, G.; Bartolini, S.; Rossi, E.; Ludovini, V.; Gregorc, V.; Ligorio, C.; Cancellieri, A.; Damiani, S.; Spreafico, A.; Paties, C.; Lombardo, L.; Calandri, C.; Bellezza, Guido; Tonato, M.; Crino', Lucio | |
| Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series | 2016 | Metro, Giulio; Lunardi, Gianluigi; Bennati, Chiara; Chiarini, Pietro; Sperduti, Isabella; Ricciuti, Biagio; Marcomigni, Luca; Costa, Cinzia; Crino', Lucio; Floridi, Piero; Gori, Stefania; Chiari, Rita | |
| ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients Results of the First Italian External Quality Assurance Scheme | 2014 | Marchetti, A; Barberis, M; Papotti, M; Rossi, G; Franco, R; Malatesta, S; Buttitta, F; Ardizzoni, A; Crino', Lucio; Gridelli, C; Taddei, G. L.; Clemente, C; Scagliotti, G; Normanno, N; Pinto, C. | |
| An approach for optimally extending mathematical models of signaling networks using omics data | 2015 | Bianconi, Fortunato; Patiti, Federico; Baldelli, Elisa; Crino', Lucio; Valigi, Paolo | |
| An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy | 2012 | Grunwald, V; Karakiewicz, Pi; Bavbek, Se; Miller, K; Machiels, Jp; Lee, Sh; Larkin, J; Bono, P; Rha, Sy; Castellano, D; Blank, Cu; Knox, Jj; Hawkins, R; Anak, O; Rosamilia, M; Booth, J; Pirotta, N; Bodrogi, I; Crino', Lucio; REACT Study, Group | |
| Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer | 2019 | Baldelli, Elisa; Hodge, K. Alex; Campbell, Michael J.; Bellezza, Guido; Demsko, Perry; Ludovini, Vienna; Sidoni, Angelo; Vandenberg, Scott; Bolen, Jennifer; Mandarano, Martina; Shah, Neil; Blackburn, Mattew; Liotta, Lance; Crino', Lucio; Giaccone, Giuseppe; Petricoin III, Emanuel F.; Pierobon, Mariaelena | |
| Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment | 2014 | Marchetti, A; Grammastro, M. D.; Felicioni, L; Malatesta, S; Filice, G; Centi, I; Pas, T. D.; Santoro, A; Chella, A; Brandes, A. A.; Venturino, P; Cuccurullo, F; Crino', Lucio; Buttitta, F. | |
| Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors. | 2008 | Ludovini, V.; Pistola, L.; Gregorc, V.; Rulli, E.; Floriani, I.; Di Carlo, L.; Ragusa, Mark; Daddi, Giuliano; Betti, M.; Tofanetti, F.; Bellezza, Guido; Sidoni, Angelo; Tognellini, R.; Crino', Lucio; Tonato, M. |